Home
NTRA
NTRA News

Latest Natera Inc. (NTRA) News on September 18, 2025

Why Natera (NTRA) Stock Is Trading Lower Today

StockStory

6 days ago

Why Natera (NTRA) Stock Is Trading Lower Today

Discover September 2025's Stocks That May Be Trading Below Estimated Value

Simply Wall St.

7 days ago

Discover September 2025's Stocks That May Be Trading Below Estimated Value

Why Natera (NTRA) Shares Are Falling Today

StockStory

8 days ago

Why Natera (NTRA) Shares Are Falling Today

3 Reasons We’re Fans of Natera (NTRA)

StockStory

9 days ago

3 Reasons We’re Fans of Natera (NTRA)

Natera (NTRA): How the ARCHER Trial May Shape Future Valuation After Key Signatera Milestone

Simply Wall St.

10 days ago

Natera (NTRA): How the ARCHER Trial May Shape Future Valuation After Key Signatera Milestone

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

GlobeNewswire

16 days ago

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics

Insider Monkey

17 days ago

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics

Health Care Roundup: Market Talk

The Wall Street Journal

20 days ago

Health Care Roundup: Market Talk

Why Natera (NTRA) Stock Is Down Today

StockStory

20 days ago

Why Natera (NTRA) Stock Is Down Today

Why Is NeoGenomics (NEO) Stock Soaring Today

StockStory

20 days ago

Why Is NeoGenomics (NEO) Stock Soaring Today

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

Benzinga

20 days ago

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

MT Newswires

20 days ago

Sector Update: Health Care Stocks Decline Premarket Friday

MT Newswires

20 days ago

Sector Update: Health Care

Natera Provides Update on Patent Litigation with NeoGenomics

Business Wire

20 days ago

Natera Provides Update on Patent Litigation with NeoGenomics

MT Newswires

20 days ago

NeoGenomics Says Court Decides to Invalidate Natera's Asserted Patents; Shares up Pre-Bell

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

Business Wire

24 days ago

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

MT Newswires

a month ago

Natera Introduces AI Models to Speed Up Diagnostic and Therapeutic Innovation

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

Business Wire

a month ago

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

Business Wire

a month ago

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

1 Healthcare Stock to Own for Decades and 2 We Find Risky

StockStory

a month ago

1 Healthcare Stock to Own for Decades and 2 We Find Risky

Natera (NTRA) Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancer

Simply Wall St.

a month ago

Natera (NTRA) Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancer

Natera pursues ctDNA assay approval after Phase III victory

Clinical Trials Arena

a month ago

Natera pursues ctDNA assay approval after Phase III victory

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target

Insider Monkey

3 months ago

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

StockStory

3 months ago

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

3 Reasons We Love Natera (NTRA)

StockStory

3 months ago

3 Reasons We Love Natera (NTRA)

High Growth US Tech Stocks To Watch In June 2025

Simply Wall St.

3 months ago

High Growth US Tech Stocks To Watch In June 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase

StockStory

3 months ago

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase

MT Newswires

3 months ago

Natera Says Signatera Cancer Test Approved for Medicare Coverage

Natera Announces Medicare Coverage for Signatera™ Genome

Business Wire

3 months ago

Natera Announces Medicare Coverage for Signatera™ Genome

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study

Simply Wall St.

3 months ago

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025

Business Wire

4 months ago

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025

3 Mid-Cap Stocks Worth Your Attention

StockStory

4 months ago

3 Mid-Cap Stocks Worth Your Attention

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

Business Wire

4 months ago

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks In The US Market

3 Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

4 months ago

3 Stocks That May Be Trading Below Their Estimated Value

Natera, Inc. (NTRA): A Bull Case Theory

Insider Monkey

4 months ago

Natera, Inc. (NTRA): A Bull Case Theory

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

4 months ago

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Natera First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Natera First Quarter 2025 Earnings: Beats Expectations

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Natera Inc Earnings Call

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance

GuruFocus.com

4 months ago

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

4 months ago

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales

StockStory

4 months ago

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales

Associated Press Finance

4 months ago

Natera: Q1 Earnings Snapshot

Natera Reports First Quarter 2025 Financial Results

Business Wire

4 months ago

Natera Reports First Quarter 2025 Financial Results

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress

Business Wire

4 months ago

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

4 months ago

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows

Business Wire

4 months ago

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows

What To Expect From Natera’s (NTRA) Q1 Earnings

StockStory

4 months ago

What To Expect From Natera’s (NTRA) Q1 Earnings

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas

Medical Device Network

4 months ago

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Business Wire

4 months ago

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Natera to Report its First Quarter Results on May 8, 2025

Business Wire

5 months ago

Natera to Report its First Quarter Results on May 8, 2025

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study

Simply Wall St.

5 months ago

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

Business Wire

5 months ago

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

StockStory

5 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

StockStory

5 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now

Insider Monkey

5 months ago

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Business Wire

5 months ago

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

Business Wire

5 months ago

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Investor's Business Daily

5 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value

Simply Wall St.

5 months ago

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

StockStory

5 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

High Growth Tech Stocks In US With Potential For Expansion

Simply Wall St.

5 months ago

High Growth Tech Stocks In US With Potential For Expansion

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

StockStory

5 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

Natera (NasdaqGS:NTRA) Climbs 11% in One Week

Simply Wall St.

5 months ago

Natera (NasdaqGS:NTRA) Climbs 11% in One Week

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?

Simply Wall St.

5 months ago

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love

Insider Monkey

5 months ago

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love

3 Reasons NTRA Has Explosive Upside Potential

StockStory

5 months ago

3 Reasons NTRA Has Explosive Upside Potential

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Motley Fool

5 months ago

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory

5 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Business Wire

6 months ago

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Insider Monkey

6 months ago

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Insider Monkey

6 months ago

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

StockStory

6 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

Insider Monkey

6 months ago

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

6 months ago

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

6 months ago

Exploring Three High Growth Tech Stocks In The US Market

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Simply Wall St.

6 months ago

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Why Is Natera (NTRA) Stock Soaring Today

StockStory

6 months ago

Why Is Natera (NTRA) Stock Soaring Today

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Business Wire

6 months ago

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

MT Newswires

6 months ago

Natera Set to Continue Upside Surprises During 2025, Beyond, Morgan Stanley Says

MT Newswires

7 months ago

Natera Granted US Patent for Testing Single Nucleotide Variants

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD

Business Wire

7 months ago

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD

Natera Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

7 months ago

Natera Full Year 2024 Earnings: Beats Expectations

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Simply Wall St.

7 months ago

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Natera Inc Earnings Call

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements

GuruFocus.com

7 months ago

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

7 months ago

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales

StockStory

7 months ago

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire

7 months ago

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

Natera (NTRA) Q4 Earnings: What To Expect

StockStory

7 months ago

Natera (NTRA) Q4 Earnings: What To Expect

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

7 months ago

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect

MT Newswires

7 months ago

Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

Business Wire

7 months ago

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio

Insider Monkey

7 months ago

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio

Natera (NTRA) Surged on Blowout Quarterly Results

Insider Monkey

7 months ago

Natera (NTRA) Surged on Blowout Quarterly Results

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

Business Wire

7 months ago

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

Schrodinger Stock Scores IBD Rating Upgrade

Investor's Business Daily

7 months ago

Schrodinger Stock Scores IBD Rating Upgrade

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

Business Wire

7 months ago

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

Share on Social Networks: